BOOSTER THERAPEUTICS

Serial Number 97312047
651

Registration Progress

Application Filed
Mar 14, 2022
Under Examination
Approved for Publication
Published for Opposition
Registered

Trademark Image

BOOSTER THERAPEUTICS

Basic Information

Serial Number
97312047
Filing Date
March 14, 2022
Drawing Code
4

Status Summary

Current Status
Active
Status Code
651
Status Date
Jul 15, 2025
Application
Pending
Classes
005 042

Rights Holder

Booster Therapeutics GmbH

16
Address
Schluterstr 36
Berlin D-10629
DE

Ownership History

Booster Therapeutics GmbH

Original Applicant
16
Berlin DE

Legal Representation

Attorney
Nicholas D. Wells

USPTO Deadlines

All Deadlines Cleared

All 3 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

21 events
Date Code Type Description Documents
Jul 17, 2025 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Jul 17, 2025 ERSI I TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED Loading...
Jul 17, 2025 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Jul 15, 2025 GNS2 O NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED Loading...
Jul 15, 2025 CNSI R SUSPENSION INQUIRY WRITTEN Loading...
Jul 15, 2025 GNSI S INQUIRY TO SUSPENSION E-MAILED Loading...
Jul 7, 2025 RCCK S SUSPENSION CHECKED - TO ATTORNEY FOR ACTION Loading...
Jan 6, 2025 RCSC S REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED Loading...
Jan 3, 2024 RCSC S REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED Loading...
May 2, 2023 GNS3 O NOTIFICATION OF LETTER OF SUSPENSION E-MAILED Loading...
May 2, 2023 GNSL S LETTER OF SUSPENSION E-MAILED Loading...
May 2, 2023 CNSL R SUSPENSION LETTER WRITTEN Loading...
Apr 4, 2023 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Apr 3, 2023 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Apr 3, 2023 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Jan 3, 2023 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Jan 3, 2023 GNRT F NON-FINAL ACTION E-MAILED Loading...
Jan 3, 2023 CNRT R NON-FINAL ACTION WRITTEN Loading...
Dec 23, 2022 DOCK D ASSIGNED TO EXAMINER Loading...
Mar 18, 2022 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Mar 17, 2022 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations for the treatment of the pathologies of aging, neurodegenerative diseases, brain diseases, ocular diseases, skin disorders and skin conditions, kidney diseases, liver diseases , heart diseases, urology disorders, circulatory disorders, muscle diseases, pancreas diseases, digestive system diseases, lung diseases, memory loss, fatigue, eye strain, eye disease, hearing loss, hair loss, sexual disfunction and reproductive system diseases; Compound drugs and pharmaceuticals for the use in the field of oncology, immunology, inflammatory diseases, and central nervous system disorders to treat the pathologies of aging, neurodegenerative diseases, brain diseases, ocular diseases, skin disorders and skin conditions, kidney diseases, liver diseases , heart diseases, urology disorders, circulatory disorders, muscle diseases, pancreas diseases, digestive system diseases, lung diseases, memory loss, fatigue, eye strain, eye disease, hearing loss, hair loss, sexual disfunction and reproductive system diseases, by degrading disease-causing cellular proteins; Compound drugs and pharmaceuticals for the treatment of the pathologies of aging, neurodegenerative diseases, brain diseases, ocular diseases, skin disorders and skin conditions, kidney diseases, liver diseases , heart diseases, urology disorders, circulatory disorders, muscle diseases, pancreas diseases, digestive system diseases, lung diseases, memory loss, fatigue, eye strain, eye disease, hearing loss, hair loss, sexual disfunction and reproductive system diseases, by degrading disease-causing cellular proteins; Biological reagents for medical use; Cellular function activating agents for medical purposes; Chemical reagents for medical use; Clinical diagnostic reagents; Diagnostic testing materials for medical use, namely, Diagnostic reagents for medicinal use; Diagnostic substances for medical use; Disinfectants and antiseptics; Drug delivery agents, namely, Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; Arsenic, Benzol and Chlorine detoxification agents for medical purposes; Drugs being pharmaceuticals, medical and veterinary preparations for the treatment of for the treatment of the pathologies of aging, neurodegenerative diseases, brain diseases, ocular diseases, skin disorders and skin conditions, kidney diseases, liver diseases , heart diseases, urology disorders, circulatory disorders, muscle diseases, pancreas diseases, digestive system diseases, lung diseases, memory loss, fatigue, eye strain, eye disease, hearing loss, hair loss, sexual disfunction and reproductive system diseases, caused by degrading disease-causing cellular proteins; Enzymes for medical purposes; General anaesthetics; Pharmaceuticals, medical and veterinary preparations for the treatment of for the treatment of the pathologies of aging, neurodegenerative diseases, brain diseases, ocular diseases, skin disorders and skin conditions, kidney diseases, liver diseases , heart diseases, urology disorders, circulatory disorders, muscle diseases, pancreas diseases, digestive system diseases, lung diseases, memory loss, fatigue, eye strain, eye disease, hearing loss, hair loss, sexual disfunction and reproductive system diseases, caused by degrading disease-causing cellular proteins; Sanitary preparations for medical purposes; Food for babies; Dietary supplements for human beings and animals; Sticking plasters for medical purposes; Materials for medical and surgical dressings; Material for stopping teeth; Dental wax; Disinfectants; Preparations for destroying vermin; Fungicides; Herbicides
Class 042
Medical laboratory services; Biological research; Clinical research in the field the pathologies of aging, neurodegenerative diseases, brain diseases, ocular diseases, skin disorders and skin conditions, kidney diseases, liver diseases , heart diseases, urology disorders, circulatory disorders, muscle diseases, pancreas diseases, digestive system diseases, lung diseases, memory loss, fatigue, eye strain, eye disease, hearing loss, hair loss, sexual disfunction and reproductive system diseases, by degrading disease-causing cellular proteins; Medical research; Scientific research in the nature of conducting clinical trials for others in the field of pharmaceutical products; Research and development for the pharmaceutical industry; Consultancy relating to pharmaceutical research and development; Scientific and technological services, namely, scientific research, analysis and testing research in the field the pathologies of aging, neurodegenerative diseases, brain diseases, ocular diseases, skin disorders and skin conditions, kidney diseases, liver diseases , heart diseases, urology disorders, circulatory disorders, muscle diseases, pancreas diseases, digestive system diseases, lung diseases, memory loss, fatigue, eye strain, eye disease, hearing loss, hair loss, sexual disfunction and reproductive system diseases, by degrading disease-causing cellular proteins, and scientific research and Design of computer software relating thereto; Application service provider, namely, Providing online non-downloadable computer software platforms for medical research in the field of drug discovery and drug development; Programming of a drug discovery and development computer software platform for others; Online electronic data storage; Consultancy and assistance services in the nature of website design consultancy and computer software consulting, via an online website and data network platform, in the field of medical sciences including cell metabolism, aging and cell health; Computer services, namely, hosting of an online platform in the nature of online web facilities for the archiving, evaluation, analysation and exchange of data in the fields of biological research, clinical research and medical research

Classification

International Classes
005 042